9 March, 2017
No Comments
Discover how our innovative solutions in reproductive health, gut microbiota, and inflammatory diseases are transforming medical diagnosis and treatment.
At Pronacera, we drive the future of medicine through the development of advanced genetic diagnostic tools and biotechnological treatments. Our mission is to optimize healthcare systems by providing faster and more accurate diagnostic solutions in areas such as assisted reproduction, fibromyalgia, and rare diseases.
With a strong focus on R&D&i, we lead two main lines of work:
Reproductive genomics, analyzing female infertility through the genetic study of endometrial tissue.
Gut microbiome, researching the microbial composition and its impact on digestive health.
At Pronacera, we combine science, innovation, and commitment to transform diagnostics and improve people’s lives.
We have state-of-the-art technology to advance science.
We leverage our experience to provide you with solutions that make a difference.
Each study is backed by our commitment, tailored to you.
Each member, bringing their unique expertise, enables us to achieve significant advances.
En Pronacera, creemos que la innovación científica puede cambiar vidas. Nuestro propósito es ofrecer diagnósticos precisos y tratamientos avanzados que transformen la medicina, brindando nuevas esperanzas a quienes enfrentan retos de salud complejos. Cada avance en nuestra investigación está diseñado para mejorar la calidad de vida y anticipar el futuro de la medicina personalizada.
Cualificación, transparencia, compromiso con la ciencia, pasión por la salud, innovación avanzada, responsabilidad social, honestidad y éxito.
Garantizar que la genética esté siempre al servicio de la salud y el bienestar de las personas, elevando su calidad de vida al máximo nivel.
Nuestra investigación genómica se centra en salud reproductiva y desafíos diagnósticos, comprometiéndonos con el bienestar y avance médico.
Publications about our research lines, clinical cases, and R&D developments.
We collaborate with institutions and companies from Spain, Peru, Mexico, Colombia, Argentina, and other Ibero-American countries to advance together in the development of precision medicine. These partnerships strengthen our scientific work and allow us to adapt our solutions to diverse clinical settings.
